These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16611918)

  • 1. E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death.
    Parish JL; Kowalczyk A; Chen HT; Roeder GE; Sessions R; Buckle M; Gaston K
    J Virol; 2006 May; 80(9):4580-90. PubMed ID: 16611918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway.
    Webster K; Parish J; Pandya M; Stern PL; Clarke AR; Gaston K
    J Biol Chem; 2000 Jan; 275(1):87-94. PubMed ID: 10617590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cancer cell-specific inducer of apoptosis.
    Green KL; Brown C; Roeder GE; Southgate TD; Gaston K
    Hum Gene Ther; 2007 Jun; 18(6):547-61. PubMed ID: 17572007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between the HPV-16 E2 transcriptional activator and p53.
    Massimi P; Pim D; Bertoli C; Bouvard V; Banks L
    Oncogene; 1999 Dec; 18(54):7748-54. PubMed ID: 10618715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells.
    Desaintes C; Goyat S; Garbay S; Yaniv M; Thierry F
    Oncogene; 1999 Aug; 18(32):4538-45. PubMed ID: 10467398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53.
    Hoppe-Seyler F; Butz K
    J Virol; 1993 Jun; 67(6):3111-7. PubMed ID: 8388491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleo-cytoplasmic shuttling of high risk human Papillomavirus E2 proteins induces apoptosis.
    Blachon S; Bellanger S; Demeret C; Thierry F
    J Biol Chem; 2005 Oct; 280(43):36088-98. PubMed ID: 16135518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential.
    Elbel M; Carl S; Spaderna S; Iftner T
    Virology; 1997 Dec; 239(1):132-49. PubMed ID: 9426453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification.
    Hiller T; Poppelreuther S; Stubenrauch F; Iftner T
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1262-7. PubMed ID: 16835321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Papillomavirus 16 E2 as an Apoptosis-Inducing Protein for Cancer Treatment: A Systematic Review.
    Jamal DF; Rozaimee QA; Osman NH; Mohd Sukor A; Elias MH; Shamaan NA; Das S; Abdul Hamid N
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta Human Papillomavirus 8E6 Attenuates LATS Phosphorylation after Failed Cytokinesis.
    Dacus D; Cotton C; McCallister TX; Wallace NA
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32238586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding.
    Hou SY; Wu SY; Chiang CM
    J Biol Chem; 2002 Nov; 277(47):45619-29. PubMed ID: 12239214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.
    Crook T; Tidy JA; Vousden KH
    Cell; 1991 Nov; 67(3):547-56. PubMed ID: 1657399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Productive replication of adeno-associated virus can occur in human papillomavirus type 16 (HPV-16) episome-containing keratinocytes and is augmented by the HPV-16 E2 protein.
    Ogston P; Raj K; Beard P
    J Virol; 2000 Apr; 74(8):3494-504. PubMed ID: 10729123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
    Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR
    Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP.
    Wang W; Fang Y; Sima N; Li Y; Li W; Li L; Han L; Liao S; Han Z; Gao Q; Li K; Deng D; Meng L; Zhou J; Wang S; Ma D
    Apoptosis; 2011 Jan; 16(1):55-66. PubMed ID: 20882347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes.
    Fontan CT; Das D; Bristol ML; James CD; Wang X; Lohner H; Atfi A; Morgan IM
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33298572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis.
    Sanchez-Perez AM; Soriano S; Clarke AR; Gaston K
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():3009-18. PubMed ID: 9367388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.